Price
$142.43
Increased by +1.17%
Dollar volume (20D)
144.73 M
ADR%
2.18
Earnings report date
Jul 24, 2024
Shares float
110.05 M
Shares short
2.80 M [2.55%]
Shares outstanding
111.09 M
Market cap
15.64 B
Beta
0.87
Price/earnings
18.95
20D range
126.08 142.95
50D range
124.38 142.95
200D range
117.60 142.95

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally.

The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.

It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals.

The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions.

Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Apr 23, 24 2.04
Increased by 0.00%
1.86
Increased by +9.68%
Feb 1, 24 2.15
Increased by +8.59%
2.11
Increased by +1.90%
Oct 24, 23 2.22
Decreased by -5.93%
2.19
Increased by +1.37%
Jul 26, 23 2.30
Decreased by -2.54%
2.27
Increased by +1.32%
Apr 27, 23 2.04
Decreased by -36.65%
1.97
Increased by +3.55%
Feb 2, 23 1.98
Decreased by -40.54%
1.91
Increased by +3.66%
Oct 20, 22 2.36
Decreased by -40.40%
2.19
Increased by +7.76%
Jul 21, 22 2.36
Decreased by -25.79%
2.29
Increased by +3.06%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Dec 31, 23 2.29 B
Decreased by -1.93%
192.00 M
Increased by +90.10%
Increased by +8.39%
Increased by +93.84%
Sep 30, 23 2.29 B
Decreased by -7.68%
225.00 M
Decreased by -11.42%
Increased by +9.80%
Decreased by -4.05%
Jun 30, 23 2.34 B
Decreased by -4.69%
235.00 M
Increased by +0.86%
Increased by +10.05%
Increased by +5.82%
Mar 31, 23 2.33 B
Decreased by -10.72%
202.00 M
Decreased by -42.94%
Increased by +8.67%
Decreased by -36.08%
Dec 31, 22 2.33 B
Decreased by -14.98%
101.00 M
Decreased by -74.10%
Increased by +4.33%
Decreased by -69.54%
Sep 30, 22 2.49 B
Decreased by -10.38%
254.00 M
Decreased by -49.70%
Increased by +10.22%
Decreased by -43.88%
Jun 30, 22 2.45 B
Decreased by -3.80%
233.00 M
Decreased by -63.07%
Increased by +9.50%
Decreased by -61.61%
Mar 31, 22 2.61 B
Decreased by -4.01%
354.00 M
Decreased by -24.52%
Increased by +13.56%
Decreased by -21.37%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY